By IDSE News Staff
Carefully designed cocktails of broadly neutralizing antibodies (bNAbs) could help treat HIV infection while minimizing the risk for the virus escaping treatment (eLife 2022;11. doi:10.7554/eLife.76004).
The study showed that computational approaches to selecting combinations of bNAbs based on viral genetics could help prevent viral escape, making HIV treatment more effective.
Clinical trials using a single bNAb to treat HIV have shown that some viral strains may survive